Skip to content
Finance Investment, Oil Mining Resources

BlinkLab (ASX:BB1) to participate in a clinical study on early diagnosis of dementia in partnership with Erasmus University Medical Center

BlinkLab Limited (ASX:BB1) 2 mins read

Sydney, NSW — BlinkLab Limited (ASX:BB1), a pioneering digital healthcare company specializing in AI-driven diagnostics for neurological disorders, is thrilled to announce its participation in a transformative clinical study led by Erasmus University Medical Center (Erasmus MC) in Rotterdam. This collaboration aims to enhance the early and accurate diagnosis of dementia, specifically frontotemporal dementia (FTD) and Alzheimer’s Disease (AD), through innovative AI-powered diagnostic tools.

The study will leverage BlinkLab’s cutting-edge technology in the newly established Digital Dementia Lab, a home-based testing environment designed to develop and assess digital biomarkers. These biomarkers will focus on clinically relevant behaviors to improve early diagnosis, addressing the significant global impact of dementia—currently the seventh leading cause of death worldwide with costs approximating $1.3 trillion.

Study Highlights:

  • Duration and Scope: The clinical study will span up to 24 months and involve 250 participants from the FTD Risk Cohort.
  • Innovative Approach: Utilizing BlinkLab’s smartphone-based diagnostics, including eyeblink conditioning (EBC) and prepulse inhibition of the acoustic startle reflex (PPI), to capture subtle behavioral and cognitive changes at home.
  • Strategic Collaboration: The partnership grants BlinkLab an exclusive option to license any new intellectual property arising from the study.

Henk-Jan Boele, CEO of BlinkLab commented: “BlinkLab is all about bringing basic neuroscience to society and patients. For BlinkLab the main focus remains neurodevelopmental conditions, including autism and ADHD. However, we know from science that there are opportunities for neurodegenerative conditions as well, as mentioned in our Prospectus. Our collaboration with Dr Jackie Poos at Erasmus MC will further dive into this line of research. This work will be an important driver for the transformation of mental healthcare from the current one-size-fits-all approach to a data-driven, personalised, and affordable system. I am looking forward to working with Dr Jackie Poos and we are confident that our collaboration will offer new possibilities for the advancement of dementia diagnosis and care.” 

BlinkLab’s Chairman, Brian Leedman, also highlighted the strategic importance of this collaboration, "Joining forces with a top-tier research institution like Erasmus MC further validates our innovative solutions and the potential of our technology to revolutionize the diagnosis and management of dementia, alongside our ongoing work in autism and ADHD."


About us:

BlinkLab, a company founded by neuroscientists at Princeton University, over the past several years has fully developed a smartphone based diagnostic platform for autism, ADHD, schizophrenia, and other neuropsychiatric conditions. BlinkLab’s most advanced product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention. BlinkLab is led by an experienced management team and directors with a proven track record in building companies and vast knowledge in digital healthcare, computer vision, AI and machine learning. Our Scientific Advisory Board consists of leading experts in the field of autism and brain development allowing us to bridge the most advanced technological innovations with groundbreaking scientific research. 


Contact details:

Jane Morgan

jm@janemorganmanagement.com.au

Media

More from this category

  • Finance Investment, Oil Mining Resources
  • 11/02/2025
  • 13:01
Jane Morgan Management

Amaero Fully Funded and Positioned for Commercialisation in FY2026

Sydney, Australia – 11 February 2025 – Amaero International Limited (ASX:3DA) is pleased to announce that it has successfully completed the bookbuild for an institutional placement to raise approximately A$22 million.Key Highlights Amaero successfully completed an institutional placement to raise A$22 million following strong support from existing cornerstone institutional investors as well as a new U.S-based institutional investor. Capital raising was fully subscribed by Pegasus Growth Capital, the Amaero Board, four lead institutional investors, and a new U.S-based institutional investor. Following the capital raise, Regal Funds Management and IFM Investors will join Pegasus Growth Capital and Fidelity International as substantial…

  • Contains:
  • Business Company News, Oil Mining Resources
  • 11/02/2025
  • 12:32
Jane Morgan Management

Challenger Gold Limited (ASX:CEL) Advances Towards Mining and Toll Milling at Hualilan Project

Highlights: Excellent progress towards mining and Toll Milling readiness at Hualilan. Final open pit mine design and mining schedules for Toll Milling pits completed. 10% increase in grade with the Schedule now entirely based on Indicated Resources. Initial 150,000t of material mined averages 8.7 g/t Au and 34.5 g/t Ag. Schedule delivers over 90,000t of toll milling material in first 3 months of mining. Enhanced operational flexibility as only 3 out of 4 potential pits are required. Mining schedule completion enables finalisation of contract mining and toll material haulage contracts. Toll Mill plant refurbishment commenced with equipment repairs in progress…

  • Contains:
  • Business Company News, Oil Mining Resources
  • 11/02/2025
  • 10:57
Terramin Australia Limited (ASX:TZN)

Terramin Reaffirms Scientific Basis and Economic Benefits of Bird in Hand Gold Project

KEY POINTS The Department for Energy and Mining (DEM) confirmed that BIHGP meets all environmental and regulatory requirements. No impact on water resources: Peer-reviewed studies confirm that local aquifers will remain unaffected. $220 million economic boost: The project will significantly contribute to South Australia's economy. 740 jobs created: Over 140 direct and 600 indirect employment opportunities. Ministerial decision contradicts DEM findings, raising concerns about regulatory consistency. Terramin Australia Limited (ASX: TZN) welcomes public discussion on its appeal regarding the Bird in Hand Gold Project (BIHGP) and wishes to clarify key facts following recent media coverage. Independent government assessment supports the…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.